Your browser doesn't support javascript.
loading
Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma.
Durand, Marie-Alice; Drouin, Aurélie; Mouchard, Alice; Durand, Laurine; Esnault, Clara; Berthon, Patricia; Tallet, Anne; Le Corre, Yannick; Hainaut-Wierzbicka, Ewa; Blom, Astrid; Saiag, Philippe; Beneton, Nathalie; Bens, Guido; Nardin, Charlee; Aubin, François; Dinulescu, Monica; Collin, Christine; Fromont-Hankard, Gaëlle; Cribier, Bernard; Laurent-Roussel, Sara; Cokelaere, Kristof; Houben, Roland; Schrama, David; Peixoto, Paul; Hervouet, Eric; Bachiri, Kamel; Kantar, Diala; Coyaud, Etienne; Guyétant, Serge; Samimi, Mahtab; Touzé, Antoine; Kervarrec, Thibault.
  • Durand MA; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France.
  • Drouin A; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France.
  • Mouchard A; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France; Department of Dermatology, CHRU of Tours, University of Tours, Chambray-lès-Tours, France.
  • Durand L; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France.
  • Esnault C; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France.
  • Berthon P; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France.
  • Tallet A; Platform of Somatic Tumor Molecular Genetics, CHU of Tours, University of Tours, Tours, France.
  • Le Corre Y; Dermatology Department, CHU of Angers, LUNAM University, Angers, France.
  • Hainaut-Wierzbicka E; Dermatology Department, CHU of Poitiers, University of Poitiers, Poitiers, France.
  • Blom A; Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, CARADERM Network, Boulogne-Billancourt, France; Research unit EA 4340, University of Versailles-Saint-Quentin-en-Yvelines, Paris-Saclay University, Boulogne-Billancourt, France.
  • Saiag P; Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, CARADERM Network, Boulogne-Billancourt, France; Research unit EA 4340, University of Versailles-Saint-Quentin-en-Yvelines, Paris-Saclay University, Boulogne-Billancourt, France.
  • Beneton N; Dermatology Department, CHU of Le Mans, University of Le Mans, Le Mans, France.
  • Bens G; Dermatology department, CHR Orleans, Orleans, France.
  • Nardin C; Dermatology, CHU Besançon, Besançon, France; INSERM 1098, Université Bourgogne Franche-Comté, Besançon, France.
  • Aubin F; Dermatology, CHU Besançon, Besançon, France; INSERM 1098, Université Bourgogne Franche-Comté, Besançon, France.
  • Dinulescu M; Dermatology department, CHU Rennes, Institut Dermatologique du Grand Ouest (IDGO), Rennes, France.
  • Collin C; Platform of Somatic Tumor Molecular Genetics, CHU of Tours, University of Tours, Tours, France.
  • Fromont-Hankard G; Pathology Department, CHU of Tours, University of Tours, Tours, France.
  • Cribier B; Dermatology Department, CHU of Strasbourg, University of Strasbourg, Strasbourg, France.
  • Laurent-Roussel S; Paris - La roquette, National Dermatopathology Center, Paris, France.
  • Cokelaere K; Pathology Department, Regional Hospital Jan Yperman, Ieper, Belgium.
  • Houben R; Department of Dermatology, Venerology and Allergology, University Hospital of Würzburg, Würzburg, Germany.
  • Schrama D; Department of Dermatology, Venerology and Allergology, University Hospital of Würzburg, Würzburg, Germany.
  • Peixoto P; INSERM, EFS-BFC, UMR 1098 RIGHT, University Bourgogne-Franche-Comté, Besançon, France; EPIgenetics and GENe Expression Technical Platform (EPIGENExp), University Bourgogne Franche-Comté, Besançon, France.
  • Hervouet E; INSERM, EFS-BFC, UMR 1098 RIGHT, University Bourgogne-Franche-Comté, Besançon, France; EPIgenetics and GENe Expression Technical Platform (EPIGENExp), University Bourgogne Franche-Comté, Besançon, France.
  • Bachiri K; Department of Biology, Inserm U1192, Protéomique Réponse Inflammatoire Spectrométrie de Masse-PRISM, CHU Lille, Université de Lille, Lille, France.
  • Kantar D; Department of Biology, Inserm U1192, Protéomique Réponse Inflammatoire Spectrométrie de Masse-PRISM, CHU Lille, Université de Lille, Lille, France.
  • Coyaud E; Department of Biology, Inserm U1192, Protéomique Réponse Inflammatoire Spectrométrie de Masse-PRISM, CHU Lille, Université de Lille, Lille, France.
  • Guyétant S; Pathology Department, CHU of Tours, University of Tours, Tours, France; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France.
  • Samimi M; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France; Department of Dermatology, CHRU of Tours, University of Tours, Chambray-lès-Tours, France.
  • Touzé A; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France.
  • Kervarrec T; Team "Biologie des Infections à Polyomavirus", ISP UMR 1282, INRAE, University of Tours, Tours, France; Pathology Department, CHU of Tours, University of Tours, Tours, France. Electronic address: thibaultkervarrec@yahoo.fr.
J Invest Dermatol ; 143(10): 1937-1946.e7, 2023 10.
Article en En | MEDLINE | ID: mdl-37037414
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Poliomavirus de Células de Merkel Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Poliomavirus de Células de Merkel Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article